Skip to main content
SpringerLink
Log in

Optimal criteria for transcatheter closure of Fontan fenestration: a single-center experience with a review of literature

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Fenestration closure is considered to remove the persistent right-to-left shunt after the Fontan operation. However, the criteria for effective transcatheter closure of fenestration to avoid both acute and chronic Fontan failure have not been clarified. The objective of this study was to describe the hemodynamic data with test occlusion of the Fontan fenestration for patients who underwent a closure and those who did not, along with subsequent development of Fontan-associated diseases (FAD) at follow-up. This was a retrospective study conducted to assess the outcome of Fontan fenestration closure at Children’s Hospital of Michigan over 27 years (1993–2019). The inclusion criteria were patients undergoing cardiac catheterization indicated for Fontan fenestration closure. Data were compared between the two groups: closure and non-closure patients. Baseline characteristics and hemodynamic variables with the fenestration occlusion test were analyzed. The primary outcome was the development of composite events of death/transplant, deteriorated New York Heart Association class symptoms, or FAD. Among the 38 patients who were brought to the catheterization laboratory, 33 received fenestration closure and 5 did not. On a median follow-up of 3.4 years (range, 1 month–12.6 years), the incidence of primary adverse outcomes was 13% (5/38). The incidence of primary outcome was significantly higher in the non-closure group (60% vs. 6%, p < 0.01). The non-closure group had a higher incidence of moderate or severe atrioventricular valve regurgitation, New York Heart Association class III symptoms, use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, furosemide use, and sildenafil use. The multivariable logistic regression model showed that the hemodynamic variables associated with the non-closure group were mean left atrial pressure (odds ratio 1.74, p < 0.05) and change of mean Fontan pressure at the balloon occlusion (odds ratio 2.2, p < 0.05). The judgment of fenestration closure appeared appropriate in our cohort. Fontan fenestration closure may not be advisable in cases with a high baseline left atrial pressure or a significant increase in Fontan pressure on balloon occlusion testing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C (2002) Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study. Circulation 105:207–212

    Article  Google Scholar 

  2. Meadows J, Lang P, Marx G, Rhodes J (2008) Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory response to exercise. J Am Coll Cardiol 52:108–113

    Article  Google Scholar 

  3. Momenah TS, Eltayb H, Oakley RE, Qethamy HA, Faraidi YA (2008) Effects of transcatheter closure of Fontan fenestration on exercise tolerance. Pediatr Cardiol 29:585–588

    Article  Google Scholar 

  4. Kotani Y, Chetan D, Saedi A, Saedi A, Zhu J, Grosse-Wortmann L, Coles JG, Caldarone CA, Arsdell GSV, Honjo O (2014) Persistent fenestration may be a marker for physiologic intolerance after Fontan completion. J Thorac Cardiovasc Surg 148:2532–2538

    Article  Google Scholar 

  5. Garekar S, Walters HL, Delius RE, Thomas RL, Ross RD (2006) Intermediate outcomes of fenestrated Fontan procedures. J Thorac Cardiovasc Surg 131:247–249

    Article  CAS  Google Scholar 

  6. John AS, Johnson JA, Khan M, Driscoll DJ, Warnes CA, Cetta F (2014) Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 64:54–62

    Article  Google Scholar 

  7. Hijazi ZM, Fahey JT, Kleinman CS, Kopf GS, Hellenbrand WE (1992) Hemodynamic evaluation before and after closure of fenestrated Fontan. An acute study of changes in oxygen delivery. Circulation 86:196–202

    Article  CAS  Google Scholar 

  8. Feltes TF, Bacha E, Beekman RH III, Cheatham JP, Feinstein JA, Gomes AS, Hijazi ZM, Ing FF, Moor M, Morrow WR, Mullins CE, Taubert KA, Zahn EM, American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the YoungCouncil on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, American Heart Association (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123:2607–2652

    Article  Google Scholar 

  9. Bridges ND, Lock JE, Mayer JE Jr, Burnett J, Castaneda AR (1995) Cardiac catheterization and test occlusion of the interatrial communication after the fenestrated Fontan operation. J Am Coll Cardiol 25:1712–1717

    Article  CAS  Google Scholar 

  10. Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ (2000) Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation 102:2094–2099

    Article  CAS  Google Scholar 

  11. Moore JW, Murdison KA, Baffa GM, Kashow K, Murphy JD (2000) Transcatheter closure of fenestrations and excluded hepatic veins after fontan: versatility of the Amplatzer device. Am Heart J 140:534–540

    Article  CAS  Google Scholar 

  12. Pihkala J, Yazaki S, Mehta R, Lee KJ, Chaturvedi R, McCrindle BW, Arsdell GV, Benson LN (2007) Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: medium-term outcomes. Catheter Cardiovasc Interv 69:1007–1014

    Article  Google Scholar 

  13. Masura J, Bordacova L, Tittel P, Berden P, Podnar T (2008) Percutaneous management of cyanosis in Fontan patients using Amplatzer occluders. Catheter Cardiovasc Interv 71:843–849

    Article  Google Scholar 

  14. Al-Hay AA, Abushaban L, Al-Qbandi MA, Alanbaei M (2011) Occlusion of Fontan fenestrations using Amplatzer septal occluder. Int J Cardiovasc Imaging 27:483–490

    Article  Google Scholar 

  15. Malekzadeh-Milani S, Ladouceur M, Bajolle F, Bonnet D, Boudjemline Y (2015) Closure of Fontan fenestration with the use of covered stents: short- and mid-term results in a cohort of 50 patients. Cardiol Young 25:868–873

    Article  Google Scholar 

  16. Pihkala JI, Järvelä M, Boldt T, Jokinen E, Liikanen I, Mattila I, Eerola A (2016) Fate of fenestration in children treated with fontan operation. Catheter Cardiovasc Interv 87:E233–E239

    Article  Google Scholar 

  17. Góreczny S, Dryżek P, Morgan GJ, Kula AM, Moll JJ, Moll JA, Qureshi S, Moszura T (2017) Fenestration closure with Amplatzer Duct Occluder II in patients after total cavo-pulmonary connection. Arch Med Sci 13:337–345

    Article  Google Scholar 

  18. Webb MK, Hunter LE, Kremer TR, Huddleston CB, Fiore AC, Danon S (2020) Extracardiac Fontan fenestration device closure with Amplatzer Vascular Plug II and Septal Occluder: procedure results and medium-term follow-up. Pediatr Cardiol 41:703–708

    Article  Google Scholar 

  19. Itkin M, Piccoli DA, Nadolski G, Rychik J, DeWitt A, Pinto E, Rome J, Dori Y (2017) Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 69:2929–2937

    Article  CAS  Google Scholar 

  20. Dori Y, Keller MS, Rome JJ, Gillespie MJ, Glatz AC, Dodds K, Goldberg DJ, Goldfarb S, Rychik J, Itkin M (2016) Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 133:1160–1170

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Children’s Hospital of Michigan, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, 3901 Beaubien Blvd, Detroit, MI, 48201-2119, USA

    Yuki Kawasaki, Takeshi Sasaki, Thomas J. Forbes, Robert D. Ross & Daisuke Kobayashi

  2. Department of Pediatric Cardiology, Osaka City General Hospital Pediatric Medical Center, Osaka, Japan

    Yuki Kawasaki & Takeshi Sasaki

Authors
  1. Yuki Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeshi Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J. Forbes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert D. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daisuke Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daisuke Kobayashi.

Ethics declarations

Conflict of interest

The authors declare that there are no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 145 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawasaki, Y., Sasaki, T., Forbes, T.J. et al. Optimal criteria for transcatheter closure of Fontan fenestration: a single-center experience with a review of literature. Heart Vessels 36, 1246–1255 (2021). https://doi.org/10.1007/s00380-021-01798-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01798-y

Keywords

Search

Navigation